Literature DB >> 32488217

The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.

Ehud Chorin1, Matthew Dai2, Eric Shulman2, Lalit Wadhwani2, Roi Bar-Cohen2, Chirag Barbhaiya2, Anthony Aizer2, Douglas Holmes2, Scott Bernstein2, Michael Spinelli2, David S Park2, Larry A Chinitz2, Lior Jankelson3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32488217     DOI： 10.1038/s41591-020-0888-2

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  120 in total

1.  Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.

Authors:  Burcu Uğurlu Ilgın; İrem Müge Akbulut Koyuncu; Emrullah Kızıltunç
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

Review 2.  Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths.

Authors:  Shivraj Padiyar; Debashish Danda
Journal:  Eur J Rheumatol       Date:  2020-10-08

Review 3.  Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality.

Authors:  Guoliang Li; Ardan M Saguner; Jiaqi An; Yuye Ning; John D Day; Ligang Ding; Xavier Waintraub; Jie Wang
Journal:  Cardiol J       Date:  2020-08-13       Impact factor: 2.737

Review 4.  Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection.

Authors:  Mohammad Rafi Khezri; Naime Majidi Zolbanin; Morteza Ghasemnejad-Berenji; Reza Jafari
Journal:  Eur J Pharmacol       Date:  2021-05-17       Impact factor: 5.195

Review 5.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

6.  Predicting QT interval prolongation in patients diagnosed with the 2019 novel coronavirus infection.

Authors:  Wei Zhao; Nikhil Gandhi; Saif Affas; Susan Szpunar; Nancy Mesiha; Louis Saravolatz
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-05-07       Impact factor: 1.485

7.  Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.

Authors:  Srinivasa Reddy Bonam; Sylviane Muller; Jagadeesh Bayry; Daniel J Klionsky
Journal:  Autophagy       Date:  2020-06-24       Impact factor: 16.016

8.  Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City.

Authors:  Oscar Arturo Lozano-Cruz; José Víctor Jiménez; Antonio Olivas-Martinez; Edgar Ortiz-Brizuela; José Luis Cárdenas-Fragoso; Daniel Azamar-Llamas; Sergio Rodríguez-Rodríguez; Jorge Carlos Oseguera-Moguel; Joel Dorantes-García; Clemente Barrón-Magdaleno; Aldo C Cázares-Diazleal; Carla Marina Román-Montes; Karla María Tamez-Torres; Bernardo Alfonso Martínez-Guerra; Alfonso Gulias-Herrero; María Fernanda González-Lara; Alfredo Ponce-de-León-Garduño; David Kershenobich-Stalnikowitz; José Sifuentes-Osornio
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

Review 9.  Comparing of the First Electrocardiographic Variables in Patients with Newly Diagnosed COVID-19 with Healthy Men Volunteer: A Systematic Review and Meta-Analysis.

Authors:  Mahdieh Arian; Ali Valinejadi; Farveh Vakilian
Journal:  Iran J Public Health       Date:  2021-01       Impact factor: 1.429

Review 10.  Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis.

Authors:  Donovan A McGrowder; Fabian Miller; Melisa Anderson Cross; Lennox Anderson-Jackson; Sophia Bryan; Lowell Dilworth
Journal:  Diseases       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.